All In Biotech

Drug Trial Radar · NCT05929079

A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight

A Master Protocol to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight: A Randomized Double-Blind, Placebo-Controlled Trial

Last checked: Nov 20, 2026Latest source record: Jul 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,152 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,152

Actual

Start

Jul 11, 2023

Primary completion

Jun 16, 2026

Study completion Jun 16, 2026

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Jul 3, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have obesity or overweight (J1I-MC-GZBK master protocol) including a subset of participants who have obstructive sleep apnea (OSA) (J1I-MC-GSA2). The study will last about 89 weeks and will include up to 24 visits.

Conditions

  • Type 2 Diabetes
  • Obesity
  • Overweight
  • Obstructive Sleep Apnea

Interventions

  • RetatrutideDrug

    Administered SC

  • PlaceboDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change from Baseline in Body WeightTime frame: Baseline, Week 80
  2. Change from Baseline in Apnea-Hypopnea Index (AHI) for GSA2 SubsetTime frame: Baseline, Week 80

Locations

98 sites in 8 countries. Site status is shown where the registry gives one.

  • Pinnacle Research Group, LLC

    Anniston, Alabama

  • Cullman Clinical Trials

    Cullman, Alabama

  • Preferred Research Partners

    Little Rock, Arkansas

  • Core Healthcare Group

    Cerritos, California

  • Velocity Clinical Research, Westlake

    Los Angeles, California

  • Valley Clinical Trials, Inc.

    Northridge, California

  • Diablo Clinical Research, Inc.

    Walnut Creek, California

  • Chase Medical Research, LLC

    Waterbury, Connecticut

  • Excel Medical Clinical Trials

    Boca Raton, Florida

  • Teradan Clinical Trials, LLC

    Brandon, Florida

  • Fleming Island Center for Clinical Research

    Fleming Island, Florida

  • Therafirst Medical Center

    Fort Lauderdale, Florida

  • Clinical Site Partners LLC, dba Flourish Research

    Miami, Florida

  • Quantum Clinical Trials

    Miami Beach, Florida

  • Renstar Medical Research

    Ocala, Florida

  • Clinical Research Center of Florida

    Pompano Beach, Florida

  • Palm Beach Research Center

    West Palm Beach, Florida

  • Clinical Site Partners, LLC dba Flourish Research

    Winter Park, Florida

  • NeuroTrials Research Inc

    Atlanta, Georgia

  • Centricity Research Rincon Pulmonology

    Rincon, Georgia

  • East-West Medical Research Institute

    Honolulu, Hawaii

  • Brengle Family Medicine

    Indianapolis, Indiana

  • MedVadis Research Corporation

    Waltham, Massachusetts

  • StudyMetrix Research

    City of Saint Peters, Missouri

  • Las Vegas Medical Research

    Las Vegas, Nevada

  • Mid Hudson Medical Research

    New Windsor, New York

  • Monroe Biomedical Research

    Monroe, North Carolina

  • Carteret Medical Group

    Morehead City, North Carolina

  • Lillestol Research

    Fargo, North Dakota

  • CTI Clinical Research Center

    Cincinnati, Ohio

  • Intrepid Research

    Cincinnati, Ohio

  • Preferred Primary Care Physicians, Preferred Clinical Research (Ofc 18)

    Pittsburgh, Pennsylvania

  • Preferred Primary Care Physicians

    Uniontown, Pennsylvania

  • Tribe Clinical Research, LLC

    Greenville, South Carolina

  • Trial Management Associates

    Myrtle Beach, South Carolina

  • Tribe Clinical Research - Spartanburg

    Spartanburg, South Carolina

  • FutureSearch Trials of Neurology

    Austin, Texas

  • Velocity Clinical Research, Dallas

    Dallas, Texas

  • Advanced Research Institute

    Ogden, Utah

  • Northwest Clinical Research Center

    Bellevue, Washington

Showing 40 of 98 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.